[Risk factors and clinical outcomes for vancomycin-resistant enterococcus colonization on intensive care unit admission]
- PMID: 23703606
- DOI: 10.4040/jkan.2013.43.2.287
[Risk factors and clinical outcomes for vancomycin-resistant enterococcus colonization on intensive care unit admission]
Abstract
Purpose: The purpose of this study was to identify vancomycin-resistant enterococcus (VRE) colonization rate in patients admitted to the intensive care unit (ICU), associated risk factors and clinical outcomes for VRE colonization.
Methods: Of the 7,703 patients admitted to the ICUs between January, 2008 and December, 2010, medical records of 554 VRE colonized and 503 uncolonized patients were reviewed retrospectively. To analyzed the impact of colonization on patients' clinical outcomes, 199 VRE colonized patients were matched with 199 uncolonized patients using a propensity score matching method.
Results: During the study period, 567 (7.2%) of the 7,703 patients were colonized with VRE. Multivariate analysis identified the following independent risk factors for VRE colonization: use of antibiotics (odds ratio [OR]=3.33), having bedsores (OR=2.92), having invasive devices (OR=2.29), methicillin-resistant Staphylococcus aureus co-colonization (OR=1.84), and previous hospitalization (OR=1.74). VRE colonized patients were more likely to have infectious diseases than uncolonized patients. VRE colonization was associated with prolonged hospitalization and higher mortality.
Conclusion: Strict infection control program including preemptive isolation for high-risk group may be helpful. Further research needs to be done to investigate the effects of active surveillance program on the incidence of colonization or infection with VRE in the ICU.
Keywords: Enterococcus; Infection control; Intensive care units; Vancomycin resistance.
Similar articles
-
Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.Am J Infect Control. 2014 Oct;42(10):1062-6. doi: 10.1016/j.ajic.2014.06.024. Am J Infect Control. 2014. PMID: 25278394
-
Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis.Am J Infect Control. 2009 Nov;37(9):734-40. doi: 10.1016/j.ajic.2008.09.025. Epub 2009 Feb 1. Am J Infect Control. 2009. PMID: 19188004
-
Risk factors for positive admission surveillance cultures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in a neurocritical care unit.Crit Care Med. 2011 Oct;39(10):2322-9. doi: 10.1097/CCM.0b013e3182227222. Crit Care Med. 2011. PMID: 21705905
-
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: recognition and prevention in intensive care units.Crit Care Med. 2010 Aug;38(8 Suppl):S335-44. doi: 10.1097/CCM.0b013e3181e6ab12. Crit Care Med. 2010. PMID: 20647791 Review.
-
Vancomycin-resistant enterococci: colonization, infection, detection, and treatment.Mayo Clin Proc. 2006 Apr;81(4):529-36. doi: 10.4065/81.4.529. Mayo Clin Proc. 2006. PMID: 16610573 Review.
Cited by
-
Screening for Intestinal Colonization with Vancomycin Resistant Enterococci and Associated Risk Factors among Patients Admitted to an Adult Intensive Care Unit of a Large Teaching Hospital.J Clin Diagn Res. 2016 Sep;10(9):DC06-DC09. doi: 10.7860/JCDR/2016/20562.8418. Epub 2016 Sep 1. J Clin Diagn Res. 2016. PMID: 27790430 Free PMC article.
-
Soft Tissue and Wound Infections Due to Enterococcus spp. Among Hospitalized Trauma Patients in a Developing Country.J Glob Infect Dis. 2014 Oct;6(4):189-93. doi: 10.4103/0974-777X.145253. J Glob Infect Dis. 2014. PMID: 25538459 Free PMC article.
-
Vancomycin Resistant Enterococci Prevalence, Antibiotic Susceptibility Patterns and Colonization Risk Factors Among HIV-Positive Patients in Health-Care Facilities in Debre Berhan Town, Ethiopia.Infect Drug Resist. 2024 Jan 3;17:17-29. doi: 10.2147/IDR.S440479. eCollection 2024. Infect Drug Resist. 2024. PMID: 38192330 Free PMC article.
-
Previous antibiotic therapy as independent risk factor for the presence of vancomycin-resistant enterococci in surgical inpatients. Results from a matched case-control study.BMC Infect Dis. 2023 May 2;23(1):274. doi: 10.1186/s12879-023-08238-4. BMC Infect Dis. 2023. PMID: 37131139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical